Who are Labcorp's decision-makers?
Labcorp is led by Adam Schechter. Sellers should map decisions across the executive sponsor, business-unit owner, procurement, legal, security, privacy, compliance, finance, clinical or scientific stakeholders, and implementation owners.
- CEO
- Adam Schechter
- CFO/key exec
- Glenn Eisenberg
- Founded
- 1978
- Employees
- 67,000+
- HQ
- Burlington, NC
- Status
- NYSE: LH
- Adam SchechterChairman and Chief Executive OfficerCEO since 2019Leads Labcorp's diagnostics and biopharma laboratory services strategy.
- Glenn EisenbergExecutive Vice President and Chief Financial OfficerCFO since 2014Oversees finance, capital allocation, and investor planning.
- Dr. Brian CaveneyPresident, Diagnostics and Chief Medical and Scientific OfficerSenior medical leaderLeads diagnostics and medical/scientific strategy.
- Lance BerberianExecutive Vice President and Chief Information and Technology OfficerTechnology leaderLeads technology, security, and digital operations.
Who leads Labcorp?
Labcorp's leadership team combines enterprise healthcare operations, finance, R&D, clinical, product, technology, legal, manufacturing, and commercial roles. The CEO and CFO set capital priorities, while business-unit leaders decide which operational problems become funded initiatives.
Who actually makes buying decisions at Labcorp?
Buying decisions usually start with a business-unit sponsor, then move through procurement, finance, legal, information security, privacy, compliance, quality, and implementation owners. Clinical, reimbursement, regulatory, or scientific stakeholders become essential whenever the purchase touches patient care, regulated data, clinical evidence, medical products, lab workflows, or payer/provider economics.
How is Labcorp organized as it scales?
Labcorp operates through product, therapeutic-area, regional, manufacturing, commercial, and corporate functions. That creates multiple entry points, but enterprise standards for security, privacy, compliance, contracting, vendor risk, and data governance can still control the final approval path.
As of June 2026.Sources:Labcorp leadershipLabcorp annual reports
Labcorp — frequently asked questions
